Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.87B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.06B |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$512M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$425M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 2 |
Bank of America
BAC
|
+$293M |
| 3 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$273M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$266M |
| 5 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$234M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.29% |
| 2 | Healthcare | 9.07% |
| 3 | Financials | 8.9% |
| 4 | Industrials | 8.58% |
| 5 | Consumer Discretionary | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.99B
| $4.15M | ﹤0.01% |
487,162
-62,654
| -11% | -$531K |
|
2527
Fulton Financial
FULT
$4.66B
| $4.14M | ﹤0.01% |
232,171
+77,266
| +50% | +$1.43M |
|
|
ENT
2528
DELISTED
Global Eagle Entertainment Inc.
ENT
| $4.14M | ﹤0.01% |
51,923
-18,884
| -27% | -$2.46M |
|
2529
Capitol Federal Financial
CFFN
$1.09B
| $4.13M | ﹤0.01% |
282,221
-47,636
| -14% | -$730K |
|
|
FEO
2530
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
| $4.13M | ﹤0.01% |
270,499
+55,863
| +26% | +$825K |
|
2531
Shinhan Financial Group
SHG
$32.8B
| $4.13M | ﹤0.01% |
98,736
-1,032
| -1% | -$42K |
|
2532
PRA Group
PRAA
$663M
| $4.12M | ﹤0.01% |
124,350
-39,897
| -24% | -$1.5M |
|
2533
National Health Investors
NHI
$3.72B
| $4.12M | ﹤0.01% |
56,715
-1,902
| -3% | -$139K |
|
|
PNNT
2534
Pennant Park Investment Corp
PNNT
$215M
| $4.12M | ﹤0.01% |
505,942
-300,562
| -37% | -$2.42M |
|
|
OCSI
2535
DELISTED
Oaktree Strategic Income Corporation
OCSI
| $4.12M | ﹤0.01% |
466,958
-324,606
| -41% | -$2.99M |
|
2536
MGE Energy Inc
MGEE
$3B
| $4.1M | ﹤0.01% |
63,115
-5,902
| -9% | -$373K |
|
2537
Rocky Brands
RCKY
$366M
| $4.1M | ﹤0.01% |
355,164
+2,991
| +0.8% | +$34.3K |
|
|
GRX
2538
Gabelli Healthcare & Wellness Trust
GRX
$144M
| $4.1M | ﹤0.01% |
410,229
+13,221
| +3% | +$131K |
|
2539
Medifast
MED
$109M
| $4.09M | ﹤0.01% |
92,211
+8,236
| +10% | +$355K |
|
|
KATE
2540
DELISTED
Kate Spade & Company
KATE
| $4.09M | ﹤0.01% |
175,943
-549,723
| -76% | -$11.5M |
|
2541
Navigator Holdings
NVGS
$1.38B
| $4.08M | ﹤0.01% |
297,081
+253,460
| +581% | +$3M |
|
|
SPAN
2542
DELISTED
Span-America Medical Systems I
SPAN
| $4.08M | ﹤0.01% |
193,846
-3,907
| -2% | -$80.6K |
|
|
FIT
2543
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $4.08M | ﹤0.01% |
689,963
-478,552
| -41% | -$3.04M |
|
|
GMZ
2544
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
| $4.08M | ﹤0.01% |
54,661
+7,958
| +17% | +$597K |
|
2545
iShares MSCI Italy ETF
EWI
$1.01B
| $4.08M | ﹤0.01% |
158,478
+11,276
| +8% | +$276K |
|
|
SYT
2546
DELISTED
Syngenta Ag
SYT
| $4.08M | ﹤0.01% |
46,081
-208
| -0.4% | -$17.8K |
|
|
ARR
2547
Armour Residential REIT
ARR
$2.33B
| $4.06M | ﹤0.01% |
35,710
-1,220
| -3% | -$134K |
|
|
MDCO
2548
DELISTED
Medicines Co
MDCO
| $4.05M | ﹤0.01% |
82,920
-796,916
| -91% | -$36.3M |
|
2549
LSI Industries
LYTS
$859M
| $4.04M | ﹤0.01% |
400,842
-65,399
| -14% | -$634K |
|
|
EOT
2550
Eaton Vance National Municipal Opportunities Trust
EOT
$270M
| $4.03M | ﹤0.01% |
187,361
-28,184
| -13% | -$602K |
|
Similar funds
Wells Fargo's Q1 2017 Portfolio in Review
As of Q1 2017, Wells Fargo held 6,821 positions worth $308B, up 8.6% from $283B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Wells Fargo's Q1 2017 filing shows 340 new, 2,859 increased, 2,496 reduced and 297 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 1,728,127 shares worth $94.1M. The largest sale was iShares Russell 2000 ETF, an estimated $341M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 1,728,127 shares worth $94.1M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $3.87B increase.
- Wells Fargo's biggest Q1 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $341M.
- Wells Fargo fully exited Harman International Industries in Q1 2017, selling an estimated $130M.
- Wells Fargo's ten largest holdings make up 14% of its $308B portfolio in Q1 2017.
- Wells Fargo opened 340 new positions and closed 297 in Q1 2017.
- Wells Fargo's portfolio value rose 8.6% quarter-over-quarter to $308B.
Based on Wells Fargo's 13F filing for Q1 2017, filed 28 Apr 2017.